Hematology

Filter

Advancing Haemophilia Care: An EAHAD Roundtable Discussion

January 2025

Tune into the latest EMJ Webinar, featuring five key members of the European Association for Haemophilia and Allied Disorders (EAHAD), who join Jonathan Sackier to discuss the EAHAD’s mission, aims, and key projects for the coming year.

Treatment and outcome of CML patients from the EUTOS population-based registry

The European Treatment Outcome Study (EUTOS) investigated the treatment and treatment outcome of patients with chronic myeloid leukaemia (CML).

Venetoclax (ABT-199/GDC-0199) plus rituximab shows promise in relapsed/refractory CLL

n a phase 1b, open-label, dose-escalation, multicentre study of patients with relapsed or refractory chronic lymphocytic leukaemia (CLL), the combination…

Adding elotuzumab to standard treatment for myeloma reduced disease progression

ELOQUENT-2, a phase 3, randomised, open-label study of lenalidomide and dexamethasone with or without elotuzumab in patients with relapsed or refractory…

Dr Keith Stewart chairs a discussion on tumour biology-guided treatment for multiple myeloma

At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Gareth Morgan (University of Arkansas…

Clinical significance of progenitor cells in multiple myeloma

Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Leif Bergsagel (Mayo Clinic, Scottsdale, AZ) and Prof Gareth…

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society…

ASH 2014: Recent investigational advances in mantle cell lymphoma treatment

Prof Simon Rule (Derriford Hospital, Plymouth, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses recent advances in the…

EMJ

ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)

Dr Jia Ruan (Weill Cornell Medical College, New York, NY) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses the clinical relevance…

Loading posts...

« Previous 1 … 6 7 8 9 Next »